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Ca
2+ entry through store-operated Ca
2+ channels involves the
interaction at ER–PM (endoplasmic reticulum–plasma mem-
brane)junctionsofSTIM(stromalinteractionmolecule)andOrai.
STIM proteins are sensors of the luminal ER Ca
2+ concentration
and, following depletion of ER Ca
2+, they oligomerize and trans-
locate to ER–PM junctions where they form STIM puncta. Direct
binding to Orai proteins activates their Ca
2+ channel function. It
hasbeensuggestedthatanadditionalinteractionoftheC-terminal
polybasic domain of STIM1 with PM phosphoinositides could
contribute to STIM1 puncta formation prior to binding to Orai. In
the present study, we investigated the role of phosphoinositides
in the formation of STIM1 puncta and SOCE (store-operated
Ca
2+ entry) in response to store depletion. Treatment of HeLa
cells with inhibitors of PI3K (phosphatidylinositol 3-kinase)
and PI4K (phosphatidylinositol 4-kinase) (wortmannin and
LY294002) partially inhibited formation of STIM1 puncta.
Additional rapid depletion of PtdIns(4,5)P2 resulted in more
substantial inhibition of the translocation of STIM1–EYFP
(enhanced yellow ﬂuorescent protein) into puncta. The inhibition
was extensive at a concentration of LY294002 (50 μM) that
should primarily inhibit PI3K, consistent with a major role for
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 in puncta formation. Depletion
of phosphoinositides also inhibited SOCE based on measurement
oftheriseinintracellularCa
2+ concentrationafterstoredepletion.
Overexpression of Orai1 resulted in a recovery of translocation
of STMI1 into puncta following phosphoinositide depletion and,
under these conditions, SOCE was increased to above control
levels.Theseobservationssupporttheideathatphosphoinositides
arenotessentialbutcontributetoSTIM1accumulationatER–PM
junctions with a second translocation mechanism involving direct
STIM1–Orai interactions.
Key words: calcium signal, endoplasmic reticulum calcium,
Orai1, phosphoinositide, PtdIns(4,5)P2, PtdIns(3,4,5)P3,s t o r e -
operated calcium entry (SOCE), stromal interaction molecule 1
(STIM1).
INTRODUCTION
SOCE (store-operated Ca
2+ entry) is the major mechanism
for receptor-induced Ca
2+ inﬂux in non-excitable cells and is
important for Ca
2+-dependent signalling events, including cell
growth and differentiation, secretion, gene expression and Ca
2+
homoeostasis [1]. Physiologically, activation of PLC (phos-
pholipase C)-coupled receptors in the PM (plasma membrane)
generates Ins(1,4,5)P3, resulting in the subsequent release of
Ca
2+ from the ER (endoplasmic reticulum) through Ins(1,4,5)P3
receptors. The depletion of Ca
2+ from the ER store subsequently
triggersCa
2+ inﬂuxthroughSOCs(store-operatedCa
2+ channels)
inthePMtoelevate[Ca
2+]i (intracellularfreeCa
2+ concentration)
[1]. Importantly, the channels are activated not by the production
of receptor-associated signalling molecules, but by the decrease
in luminal ER Ca
2+ content [2], involving a coupling between the
ER and the PM.
Although SOCE and its associated current, ICRAC (Ca
2+ release-
activated Ca
2+ current), was discovered a number of years ago
[1], only more recently has the molecular mechanism responsible
for this ER–PM coupling been uncovered. Previously, the ER
Ca
2+-sensing protein STIM1 (stromal interaction molecule 1)
[3,4] and the PM channel Orai1 [5–7] were identiﬁed in high-
throughput RNAi (RNA interference) screens as proteins which
are essential for the activation of SOCs. STIM1 is normally
distributed throughout the ER [4,8,9], where its N-terminal EF
hand binds to Ca
2+ within the ER lumen. Depletion of Ca
2+
from within the ER lumen triggers the release of Ca
2+ from
the EF hand of STIM1, which induces the oligomerization of
the EF-SAM domains of STIM1 within the ER [10–12] and the
subsequent movement of STIM1 to ER–PM junctions where it
forms aggregates known as ‘puncta’ [4,9]. STIM1 puncta at these
sites interact with and induce the clustering of Orai1 channel
subunits to form active SOCs [13,14]. Mutational analysis of
the interacting domains of STIM1 revealed that the cytoplasmic
domain of STIM1 is necessary and sufﬁcient for the activation of
SOCE [15]. Furthermore, several recent studies have identiﬁed a
minimal region within the cytoplasmic domain of STIM1 which
is essential for the clustering of Orai1 and the activation of SOCs
[16–20].However,theSTIM1proteinalsocontainsashortlysine-
rich polybasic domain at its extreme C-terminus. Intriguingly,
in some studies, mutation or deletion of the STIM1 polybasic
domain has been shown to reduce puncta formation, SOCE and
ICRAC [8,16,17,21], suggesting that the polybasic domain may be
involved in STIM1 targeting to the PM, possibly through an inter-
action with some, as yet unidentiﬁed, PM component [8,16,21].
There are several lines of evidence to suggest that
phosphorylated inositol lipids in the PM may regulate SOCE.
First, depletion of phosphoinositides has been shown to block
both SOCE and ICRAC in several cells types [22–24]. In addition, a
previous study uncovered a requirement for both PtdIns(4,5)P2
and PtdIns(3,4,5)P3 to regulate the PM localization of many
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enhanced yellow ﬂuorescent protein; FKBP12, FK506-binding protein 12; FRB, fragment of mammalian target of rapamycin that binds FKBP12;
ﬂuo-4/AM, ﬂuo-4 acetoxymethyl ester; GFP, green ﬂuorescent protein; HEK-293, human embryonic kidney; ICRAC,C a 2+ release-activated Ca2+ current;
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proteins which contain a cluster of polybasic amino acids within
their C-termini [25]. The polybasic region of STIM1 would
make it an excellent candidate as a membrane-targeting domain
through binding to phosphoinositides [8], although other reports
have argued against a role for phosphoinositides in STIM1
translocation [26]. The present study aimed to investigate the role
of the phosphoinositides in the translocation of STIM1 and the
activationofSOCE.Ourresultssuggestthatthephosphoinositides
are PM components responsible for targeting STIM1 to ER–PM
junctionsandrevealaroleforthephosphoinositidesintheactivity
of SOCs.
MATERIALS AND METHODS
Plasmids
The plasmids for the rapamycin-inducible phosphatase system
were gifts from Dr Tamas Balla (National Institute for Child
Health and Development, Bethesda, MD, U.S.A.). The PH
(pleckstrin homology) domain of PLCδ1 cloned into GFP (green
ﬂuorescentprotein)-C1wasagiftfromDrMatildaKatan(Institute
of Cancer Research, London, U.K.). For EYFP (enhanced yellow
ﬂuorescent protein)-Rit and mCherry-Rit plasmid construction,
total RNA was extracted from approx. 100×10
6 HeLa cells
using TRIzol® reagent (Invitrogen) and was used as a template
for reverse transcription using Improm-II reverse transcriptase
(Promega) and oligo(dT)(15) priming. The resulting single-
stranded cDNA was then used as a template in PCRs to amplify
the full-length Rit protein. Full-length Rit was then used as a
template to PCR-amplify the polybasic Rit tail (nucleotides 770–
847) using speciﬁc primers containing restriction endonuclease
sites to permit subsequent subcloning into the N-terminally
tagging pEYFP-C1 vector (Clontech) or into the N-terminally
tagging mCherry-C1 vector (a gift from Professor Roger Y.
Tsien, Department of Pharmacology, University of California at
San Diego, La Jolla, CA, U.S.A.). The primers for the Rit tail
were based on the human sequence with GenBank® accession
number NM_006912. For pcDNA-Orai1 plasmid construction,
the mCherry-Orai1 plasmid described previously [27] was
used as a template to amplify full-length Orai1 using speciﬁc
primers containing restriction endonuclease sites, allowing for
subsequentsubcloningintothepcDNA3.1(−)vector(Invitrogen).
For pCerulean-Orai1 plasmid construction, the Cerulean colour
tag was excised from the pCerulean-C1 vector (a gift from
Professor David W. Piston, Department of Molecular Physiology
andBiophysics,VanderbiltUniversityMedicalCentre,Nashville,
TN, U.S.A.) by digestion using the AgeI and BsrGI restriction
endonucleases and ligated into the mCherry-Orai1 vector to
replace the mCherry tag. The STIM1-EYFP plasmid was
described previously [27], and a STIM1-ECFP (enhanced cyan
ﬂuorescent protein) plasmid was constructed in a similar manner.
Chemicals and reagents
Cell culture reagents were purchased from Invitrogen, except
for GeneJuice, which was purchased from Merck. Thapsigargin,
oligomycin, wortmannin and rapamycin were purchased from
Calbiochem. Fluo-4/AM (ﬂuo-4 acetoxymethyl ester) was
fromInvitrogen/MolecularProbes.Allotherchemicalswerefrom
Sigma.
Cells and transfection
HeLa cells were maintained in DMEM (Dulbecco’s modiﬁed
Eagle’smedium)supplementedwith10%(v/v)FBS(fetalbovine
serum), 1% penicillin and streptomycin and 1% (v/v) MEM
non-essential amino acids. Before transfection, cells were grown
to 80–90% conﬂuency in 35-mm-diameter Petri dishes with
glass bottoms (MatTek). Plasmids and transfection reagents were
added directly to the Petri dishes. Single transfection and co-
transfections were carried out using 3 μg of plasmid(s) of interest
in total per dish, supplemented with 8 μl of GeneJuice.
Solutions
The standard extracellular solution used during all experiments
contained 140 mM NaCl, 4.7 mM KCl, 2 mM CaCl2,1 . 1 3m M
MgCl2, 10 mM glucose and 10 mM Hepes (pH 7.2). For Ca
2+
imaging experiments, cells were treated with 2 μM thapsigargin
in Ca
2+-free standard solution to deplete intracellular Ca
2+ stores
andweresubsequentlyperfusedwithstandardsolutioncontaining
5m MC a
2+ topermitCa
2+ inﬂux.Allexperimentswereperformed
at room temperature (23◦C). Cells were washed three times
in standard extracellular solution and mounted in a perfusion
chamber on the stage of an inverted microscope prior to imaging.
Confocal microscopy and image analysis
Confocal images were acquired using a Leica AOBS SP2
microscope equipped with a ×63 water-immersion objective
[NA (numerical aperture), 1.2] or a ×63 oil-immersion objective
(NA, 1.4). Images of STIM1–EYFP were obtained with 496 nm
excitation light and emission ﬂuorescence selected with a 505–
550 nm band-pass ﬁlter. For excitation of RFP (red ﬂuorescent
protein)-5-phosphatase and mCherry-Rit constructs, a 594 nm
laser line was used and emission ﬂuorescence was collected
between 610 and 700 nm. For GFP (green ﬂuorescent protein)
imaging, cells were excited with the 488 nm laser line and
emission was collected between 500 and 515 nm. For CFP
(cyan ﬂuorescent protein)- or Cerulean-tagged proteins, 405 nm
excitation was used and emission ﬂuorescence collected between
450 and 490 nm. Images were processed using the CorelDraw
software package or ImageJ (National Institutes of Health). To
determine the extent of ﬂuorescence associated with the PM,
regions of interest were drawn around the outside of each cell and
immediately beneath the cell periphery. Peripheral ﬂuorescence
was calculated by subtraction of cytoplasmic ﬂuorescence from
the outer region of interest. Fluorescence values were calculated
on the basis of the mean ﬂuorescence per pixel in the respective
regions rather than total ﬂuorescence to avoid problems arising
from variations in the size of the selected regions of interest.
For quantiﬁcation of STIM1–EYFP puncta formation, the puncta
were selected as spots of high ﬂuorescence intensity ranging
from approx. 0.5 to 1.0 μm in diameter. Accuracy of puncta
quantiﬁcation was veriﬁed by independent blind counting.
Measurement of [Ca2+]i
HeLa cells were loaded with 5 μM ﬂuo-4/AM for 30 min at room
temperaturetomeasurechangesin[Ca
2+]i andwereimagedusing
a Leica AOBS SP2 confocal microscope. Fluo-4 was excited
using a 488 nm laser and emission ﬂuorescence was collected
between 495 and 545 nm. To allow for comparisons between
different cells from different experiments, ﬂuo-4 ﬂuorescence
measurements for each cell were calculated as the ratio of the
ﬂuorescence at the ﬁrst time point and, to eliminate variability
betweenexperimentsintherestingﬂuorescencelevel,thesevalues
areshownasF/F0 normalizedtothepeakratioforthecontrolcells
in each experiment.
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RESULTS
STIM1 can translocate to puncta following ATP depletion and loss
of the phosphoinositides PtdIns(4,5)P2 and PtdIns(3,4,5)P3
The phosphoinositides PtdIns(4,5)P2 and PtdIns(3,4,5)P3 have
been suggested to bind the polybasic domain of STIM1 and target
ittoER–PMjunctions[8].WehaveshownpreviouslythatSTIM1
translocation to puncta is stimulated by ATP depletion which
reducedthelevelsofPtdIns(4,5)P2 atthePM[27].W einvestigated
whetherSTIM1punctaformationisdependentonPtdIns(3,4,5)P3
by treating cells with wortmannin prior to ATP depletion. We
observed translocation into the cytosol of the polybasic tail from
the small GTPase Rit linked to mCherry as a marker for PM
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 [25]. STIM1 puncta formation
was, however, still observed after ATP depletion (results not
shown).
Activation of the rapamycin-inducible phosphatase results in rapid
depletion of PM PtdIns(4,5)P2
In the previous experiment, methods were used which would
gradually decrease PtdIns(4,5)P2 levels over a period of time as
ATP was depleted. The results could suggest that PtdIns(4,5)P2
and PtdIns(3,4,5)P3 are not essential for targeting STIM1 to
the PM, but it is possible that depletion of PtdIns(4,5)P2
and PtdIns(3,4,5)P3 under these conditions was slow. We,
therefore, investigated the potential role of phosphoinositides
in STIM1 puncta formation using a more speciﬁc and more
rapid approach to deplete the levels of PtdIns(4,5)P2 at the
PM. To enable fast depletion of PtdIns(4,5)P2 we aimed to use
a previously described inducible type IV 5-phosphatase to
speciﬁcallyhydrolysePtdIns(4,5)P2 [25,29].Thissystemisbased
on the rapamycin-stimulated heterodimerization of two proteins:
FRB [fragment of mTOR (mammalian target of rapamycin) that
binds FKBP12 (FK506-binding protein 12)] and FKBP12 itself.
In this system, FRB contains a PM-localization signal and also
a CFP (PM-FRB–CFP) or RFP (PM-FRB–RFP) tag to monitor
its localization. The FKBP12 protein is fused to a type IV 5-
phosphatase and an RFP tag (RFP–ptase-dom) and is distributed
throughout the cytosol where it is inactive in the absence of
rapamycin. In order to test the ability of this phosphatase system
to alter PtdIns(4,5)P2 levels in our hands, HeLa cells were co-
transfected with the GFP-tagged PH domain of PLCδ1 (GFP-PH-
PLC) to monitor PtdIns(4,5)P2 at the PM, along with the PM-
FRB-CFP and RFP-ptase-dom constructs (Figure 1A). Perfusion
with rapamycin (1 μM) resulted in the rapid translocation of the
RFP–ptase-dom from the cytosol to the PM and the dissociation
of GFP–PH-PLC from the PM (Figure 1B). Quantiﬁcation of the
ﬂuorescenceintensityatthePMshowedthatdissociationofGFP–
PH-PLC is complete within 2 min with no further decrease in
membraneﬂuorescenceafter2 min(Figure1B;n=6),suggesting
that PtdIns(4,5)P2 depletion is rapid and complete within this
time frame. This method therefore can be used as a robust
means of speciﬁcally and rapidly depleting PtdIns(4,5)P2 at the
PM.
Neither PtdIns(4,5)P2 nor PtdIns4P/PtdIns(3,4,5)P3 alone are
essential for targeting STIM1 to puntca
To test whether STIM1 accumulates in puncta via an interaction
with PM PtdIns(4,5)P2, cells were transfected with the STIM1-
EYFP construct along with RFP chimaeras of both the PM-
FRB-RFP and RFP-ptase-dom constructs. In this case, there
was some PM ﬂuorescence from the PM-FRB-RFP construct
prior to the addition of rapamycin (Figure 2A, upper right-
Figure 1 Activation of the inducible phosphatase results in rapid and
efﬁcient depletion of PtdIns(4,5)P2
HeLa cells were co-transfected with the GFP-PH-PLC, PM-FRB-CFP and RFP-ptase-dom
constructs.At24hpost-transfection,cellsweretreatedwithrapamycin(1μM;Rapa).Rapamycin
rapidly depleted PtdIns(4,5)P2 as shown by the removal of GFP–PH-PLC from the PM to the
cytosol (A). Quantiﬁcation of ﬂuorescence at the PM reveals that depletion is complete within
2m i n( B). Scale bar, 10μm.
hand panel), but a clear translocation of the RFP–ptase-dom
from the cytosol to the PM was visible following rapamycin
treatment (Figure 2A, lower right-hand panel). [Note that it was
necessary to use the RFP-fusion proteins of both the PM-bound
FRB and the 5-phosphatase domain so that in future experiments
we could simultaneously monitor these proteins along with the
localization of Cerulean–Orai1 and STIM1–EYFP proteins in
the same cell.] Cells were perfused with rapamycin for 1 min to
activate the phosphatase. Further perfusion with a combination of
rapamycin and the SERCA (sarcoplasmic/endoplasmic reticulum
Ca
2+-ATPase) pump inhibitor thapsigargin (2 μM) to deplete
intracellular stores failed to prevent formation of STIM1 puncta
(Figure 2A, lower left-hand panel; n=8). Quantiﬁcation of
the number of puncta per cell indicated, however, a 40%
reduction in the mean number of puncta per cell following
PtdIns(4,5)P2 depletion (see Figure 5), indicating a partial
contribution of this lipid. In cells transfected with STIM1-EYFP
alone, thapsigargin-induced STIM1 translocation was observed
afterpre-incubationwith20 μMwortmannintoinhibitbothPI3K
(phosphatidylinositol 3-kinase) and PI4K (phosphatidylinositol
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Figure 2 STIM1–EYFP translocation occurs in cells following depletion of either PtdIns(4,5)P2 or PtdIns4P/PtdIns(3,4,5)P3, but is inhibited by the depletion
of multiple phosphoinositides
HeLa cells were transfected with either STIM1-EYFP alone or co-transfected with the STIM1-EYFP, PM-FRB-RFP and RFP-ptase-dom constructs. (A) Control cells treated only with thapsigargin are
shown on the left. In cells which overexpress all three proteins, depletion of PtdIns(4,5)P2 by the rapamycin-inducible phosphatase did not prevent the translocation of STIM1–EYFP stimulated by
thapsigargin. (B) Control cells treated only with thapsigargin are shown on the left. Inhibition of PI3K and PI4K by wortmannin (20 μM) pre-treatment did not prevent thapsigargin-induced STIM1
translocation in cells expressing STIM1–EYFP alone. (C) Cells were co-transfected with the STIM1-EYFP, PM-FRB-RFP and RFP-ptase-dom constructs and perfused with 20μM wortmannin for
30min followed by addition of rapamycin. Addition of thapsigargin had little or no effect on the distribution of STIM1. Scale bars, 10μm. Rapa, rapamycin; Thapsi, thapsigargin; Wort, wortmannin.
4-kinase)anddepletePtdIns4P/PtdIns(3,4,5)P3 (Figure2B,right-
hand panel; n=20), but the mean number of puncta was again
reduced by approx. 40% (see Figure 5), arguing that PtdIns4P
andPtdIns(3,4,5)P3 arenotessentialbutalsocontributetoSTIM1
puncta formation.
Phosphoinositides together regulate STIM1 translocation to puncta
Although the previous experiments suggest that PtdIns4P,
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 contribute to but are not the
sole regulators of STIM1 clustering in puncta, they do not
rule out the possibility that these lipids in combination can
contribute to targeting STIM1 to ER–PM junctions. To test this,
HeLa cells were co-transfected with the STIM1-EYFP, PM-
FRB-RFP and RFP-ptase-dom constructs and pre-treated with
20 μM wortmannin for 30 min (Figure 2C) to inhibit PI3K and
PI4K. Addition of rapamycin for 1 min induced translocation
of the phosphatase to the membrane. Interestingly, additionally
depleting PtdIns(4,5)P2 by this method appeared to essentially
abolish thapsigargin-induced STIM1 translocation into puncta
(Figure 2C; n=22). Quantiﬁcation of STIM1 puncta (see Fig-
ure 5) indicated a 94% reduction in the mean number of puncta
per cell under these conditions that was signiﬁcantly larger than
the inhibition due to wortmannin alone, suggesting that multiple
phosphoinositides have a collective role in regulating STIM1
accumulation at ER–PM junctions.
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Figure 3 Translocation of STIM1–EYFP is inhibited by the depletion of multiple phosphoinositides in cells treated with LY294002
HeLa cells were co-transfected with the STIM1-EYFP, PM-FRB-RFP and RFP-ptase-dom constructs. (A) Cells were perfused with no additions (controls), or 50 or 300μM LY294002 for 30min
followed by addition of thapsigargin, which resulted in some STIM1 translocation into puncta under all conditions. Note that after treatment with 300μM LY294002, few ST1M1 puncta formed in
some cells (e.g. the cell marked by an asterisk). (B) Cells were perfused with 50μM LY294002 for 30min followed by addition of rapamycin. Treatment with thapsigargin had little effect on the
distribution of STIM1. (C) Cells were perfused with 300μM LY294002 for 30min followed by addition of rapamycin. Treatment with thapsigargin had little effect on the distribution of STIM1. Scale
bar, 10μm. Ly29, LY294002; Rapa, rapamycin; Thapsi, thapsigargin.
PtdIns(4,5)P2 depletion further inhibits STIM1 translocation into
puncta in cells treated with the PI3K/PI4K inhibitor LY294002
In order to conﬁrm the results found with wortmannin, similar
experiments were carried out with the alternative lipid kinase
inhibitorLY294002usingHeLacellsco-transfectedwithSTIM1-
EYFP, PM-FRB-RFP and RFP-ptase-dom constructs. In these
experiments LY294002 was used at two different concentrations
at which it has been reported to inhibit PI3K alone (50 μM) or
bothPI3KandPI4K(300 μM)[28].Followingpre-treatmentwith
the inhibitor alone, translocation into puncta was still observed in
response to thapsigargin treatment, although the mean number of
puncta per cell were reduced especially at the high concentration
of LY294002 (Figure 3A; n=5). When cells were additionally
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Figure 4 Overexpression of Orai1 rescues STIM1 puncta formation following depletion of phosphoinositides
HeLa cells were co-transfected with STIM1-EYFP, PM-FRB-RFP and RFP-ptase-dom constructs and Cerulean-Orai1. The cells were treated with 20μM wortmannin (A) followed by addition of
rapamycintodepletePtdIns(4,5)P2.OverexpressionofOrai1rescuedthapsigargin-stimulatedtranslocationofSTIM1(B).Scalebar,10μm.Rapa,rapamycin,Thapsi,thapsigargin;Wort,wortmannin.
treated with rapamycin to deplete PtdIns(4,5)P2 levels, STIM1
translocation to puncta was further inhibited and indeed was
barely detectable especially at the higher concentration of
LY29004 (Figures 3B and 3C). Quantiﬁcation of the number of
puncta formed per cell (see Figure 5) indicated a signiﬁcantly
larger effect after rapamycin treatment compared with LY294002
alone. There was a 75% reduction in the mean number of puncta
percellatthelowerconcentrationofLY294002afterphosphatase
activation with a further reduction at the higher concentration
(90% inhibition). The large effect of the low concentration of
LY294002 at which PI3K would be inhibited is consistent
with major contributory roles for the lipids PtdIns(4,5)P2 and
PtdIns(3,4,5)P3 in puncta formation.
Overexpression of Orai1 rescues STIM1 puncta formation following
phosphoinositide depletion
ItispossiblethatSTIM1istargetedtophospholipidsinthePMvia
itspolybasicdomain.Deletionormutationofthisdomainhasbeen
reported in several studies to prevent STIM1 puncta formation
and SOC activation [8,15]. It has recently been shown, however,
that overexpression of Orai1 can rescue puncta formation and
SOC activation under such conditions due to interaction of a
separate domain within the C-terminus of STIM1 directly with
Orai1 [16]. We therefore tested the prediction that STIM1 puncta
formation would be restored in cells overexpressing Orai1 in
addition to STIM1 under conditions where phosphoinositides
are depleted. In order to do this, HeLa cells were co-transfected
with the STIM1-EYFP, Cerulean-Orai1, PM-FRB-RFP and RFP-
ptase-domconstructsandpre-incubatedwithwortmannin(Figure
4A). Translocation of the phosphatase was then stimulated by
the addition of rapamycin, followed by the perfusion of cells
with a combination of rapamycin and thapsigargin to deplete
internal stores. Interestingly, translocation of STIM1–EYFP now
occurreddespitethedepletionofphosphoinositidesincellswhere
Cerulean–Orai1 was also overexpressed (Figure 4B; n=21) with
the mean number of puncta per cell not signiﬁcantly different
from control untransfected cells treated with thapsigargin (Figure
5). These results agree with previous reports which support a role
for the polybasic region of STIM1 in targeting STIM1 to the PM,
Figure 5 Quantiﬁcation of puncta formed in response to thapsigargin
treatment and the effect of depletion of PtdIns(4,5)P2 and inhibition of lipid
kinases
Cells from the various treatments used in the study were analysed and the number of puncta
formed following thapsigargin treatment counted and expressed as mean per cell+ −S.E.M.
based on the number of cells indicated in parentheses. The statistical signiﬁcance of values for
all conditions are compared with control thapsigargin-treated cells, and indicated pairwise
comparisons were determined using a two-tailed Student’s t test. Statistically signiﬁcant
differences are indicated. Ly29, LY294002; Rapa, rapamycin, Thapsi, thapsigargin; Wort,
wortmannin.
but that a second domain within Orai1 can interact with STIM1
to independently target it to the PM for SOC activation [16–18].
Phosphoinositides contribute to STIM1-mediated SOCE
A number of investigations point to a crucial role for
phosphoinositides in the activity of SOCs [22,23,30]. To
determine whether the inhibition of STIM1 puncta formation by
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Figure 6 Phosphoinositide depletion reduces store-operated Ca2+ inﬂux
but this is reversed by the overexpression of Orai1
(A) HeLa cells were transfected with the STIM1-EYFP, PM-FRB-RFP and RFP-ptase-dom
constructs. At 48 h post-transfection, cells were loaded with ﬂuo-4/AM (5μM) and incubated
inwortmannin(20μM)for30min.Intracellularstoresweredepletedwiththapsigargin(2 μM).
Re-addition of Ca2+ to the external solution 420 s later allowed the measurement of Ca2+
inﬂux in cells which had been treated with or without rapamycin (Rapa). Rapamycin treatment
resulted in the inhibition of Ca2+ inﬂux when compared with cells which had been incubated in
the absence of rapamycin, as shown in the averaged traces. Quantiﬁcation of the average peak
values of Ca2+ inﬂux from these traces revealed a signiﬁcant decrease in peak [Ca2+]i values
in rapamycin-treated cells. (B) In a similar experiment but with HeLa cells also overexpressing
Orai from pcDNA3, Ca2+ inﬂux was restored in rapamycin-treated cells to levels greater than
that of cells which had not been treated with rapamycin, as shown in the averaged traces and
the peak [Ca2+ ]i values.
phosphoinositide depletion affects SOCE, we monitored [Ca
2+]i
in HeLa cells expressing STIM1–ECFP and the PM-FRB-RFP
and RFP-ptase-dom constructs by loading them with the Ca
2+
indicator ﬂuo-4/AM. The cells were pre-treated with wortmannin
for 30 min. At the beginning of each recording, cells were
perfused with either Ca
2+-free solution or Ca
2+-free solution
containing rapamycin. Thapsigargin was subsequently added to
deplete intracellular stores. SOCE could be activated by re-
introducing Ca
2+ to the solution and [Ca
2+]i was then compared
betweencellswhichhadbeentreatedwithandwithoutrapamycin.
Thapsigargin induced efﬁcient SOCE leading to an increase in
[Ca
2+]i in control cells untreated with rapamycin (Figure 6A,
upper trace; n=27). Inﬂux was, however, greatly reduced in cells
where phosphoinositides had been depleted (Figure 6A, lower
trace; n=18). This signiﬁcant reduction was also indicated by
comparison of the peak ﬂuorescence ratio values of each trace
(Figure 6A), showing a 60% reduction after phosphoinositide
depletion. These ﬁndings suggest that phosphoinositides at the
PM contribute to SOCE under these conditions.
Overexpression of Orai1 restores Ca2+ inﬂux in cells depleted of
phosphoinositides
In Figure 4 it was shown that overexpression of Orai1 recovers
STIM1 puncta formation in cells depleted of phosphoinositides.
To investigate whether SOCE is also restored under these
conditions, cells were co-transfected with STIM-EYFP and the
RFP phosphatase system as before but in this case untagged
Orai1 was overexpressed in the same cells. Cells were loaded
Figure 7 Phosphoinositide depletion reduces store-operated Ca2+ inﬂux
due to endogenous STIM1
Cells were transfected with the PM-FRB-RFP and RFP-ptase-dom constructs. At 48 h
post-transfection, cells were loaded with ﬂuo-4/AM (5μM) and incubated with wortmannin
(20μM) for 30min and treated with rapamycin (1 μM) before thapsigargin treatment and
re-addition of Ca2+ to the external solution after 620 s. In this experiment, [Ca2+]i was
monitored in transfected (+ptase; n=22) and non-transfected cells (−ptase; n=18) in the
samemicroscopeﬁeldsanddirectlycomparedsothatallcellshadbeentreatedwithrapamycin.
with ﬂuo-4/AM and [Ca
2+]i was recorded as described above.
Surprisingly, the increase in [Ca
2+]i due to Ca
2+ inﬂux in cells
depleted of phosphoinositides was not only recovered by Orai1
overexpression, but was signiﬁcantly higher in rapamycin-treated
cells (Figure 6B, upper trace; n=15) than control cells untreated
with rapamycin (Figure 6B, lower trace; n=18). These results
suggest that, although phosphoinositides contribute to SOCE,
they are not absolutely essential for Ca
2+ inﬂux and agree
with previous reports that suggest that the interaction between
STIM1 and Orai1 is the key for activation of SOCE [16–18]. In
these conditions, Ca
2+ inﬂux appeared to be signiﬁcantly greater
following depletion of phosphoinositides, which may suggest an
additional negative role for phosphoinositides in SOCE.
Phosphoinositides contribute to SOCE mediated by endogenous
STIM1
The experiments described above on SOCE were carried
out in cells overexpressing STIM1. In order to test whether
SOCE mediated by endogenous STIM1 was affected by
phosphoinositide depletion, cells were transfected with only the
RFP phosphatase system and pre-treated with wortmannin. The
response to Ca
2+ re-addition after thapsigargin treatment was
monitored after treatment with rapamycin. A direct comparison
was made between cells in the same microscope ﬁelds that
were non-transfected cells (−ptase) and acted as controls and
transfected cells (+ptase). This experiment also rules out any
effects of rapamycin itself as all cells were exposed to the drug.
The results (Figure 7) indicated that phosphoinositide depletion
also inhibited SOCE mediated by endogenous STIM1.
DISCUSSION
Previous reports have established that the ER protein STIM1
regulates SOCE by translocating to ER–PM junctions following
intracellular store depletion and that this can be visualized as the
formation of STIM1 puncta [9,31,32]. The site of STIM1 puncta
atthePMthatiscriticalforSOCEandSTIM1clusteringhasbeen
suggested to be in part determined by lipid raft domains which
anchor it to the PM [33], but the constituent(s) within the PM
responsible for this have not been identiﬁed. Phosphoinositides
might be involved in STIM1 translocation as several studies have
pointedtoaroleforPMphosphoinositidesintheactivityofSOCs
[22–24].
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In the present study, we investigated whether the phospho-
inositides are required for STIM1 puncta formation. We used
several methods to individually or simultaneously reduce
PtdIns4P,PtdIns(4,5)P2 andPtdIns(3,4,5)P3 levelsandstudiedthe
effects of phosphoinositide depletion on the formation of STIM1
puncta at ER–PM junctions triggered by Ca
2+ store depletion.
We also investigated the consequence of phosphoinositide
depletion on STIM1-mediated SOCE. Initially, depletion of
phosphoinositides was carried out using a combination of both
high-dose wortmannin treatment at levels which have been
shown to inhibit both PI3K and PI4K [28] and ATP depletion
[27]. Under these conditions, STIM1 translocation still occurred
even though levels of PtdIns(4,5)P2 and PtdIns(3,4,5)P3 were
reduced as shown by dissociation of the mCherry-Rit reporter
from the PM before the ﬁrst signs of puncta formation (results
not shown). Although this argues against a role for the
phosphoinositides in the translocation of STIM1, it is possible
that, since ATP depletion would alter the state of phospho-
rylation of many proteins, this treatment may have other
effects on the localization of STIM1 such as uncovering an
inhibitory mechanism which normally prevents the aggregation
of STIM1 oligomers in puncta. Alternatively, ATP depletion
may not deplete the phosphoinositides sufﬁciently or rapidly
enough. It was clear that a more speciﬁc and more rapid
method for the depletion particularly of PtdIns(4,5)P2 was
required to investigate the speciﬁc roles of each of the
phosphoinositides in STIM1 translocation. For this reason, we
used an inducible phosphatase system, which has been reported
to speciﬁcally and reliably deplete PtdIns(4,5)P2 levels [29,34].
The results shown in the present study reveal a contribution of
phosphoinositides to the recruitment of STIM1, since puncta
formation was inhibited under conditions that would deplete
PtdIns4P,PtdIns(4,5)P2 andPtdIns(3,4,5)P3.Interestingly,puncta
formation was partially affected by separate depletion of either
PtdIns(4,5)P2 or PtdIns4P/PtdIns(3,4,5)P3, but depletion of all
lipidswasrequiredforanessentiallycompleteinhibitionofpuncta
formation, suggesting that STIM1 can interact with multiple
phosphoinositides in the process of puncta formation.
These results complement previous reports which have shown
that the STIM1 polybasic domain plays a role in STIM1 function
atthePM[8,16,17,21].Severalhypotheseshavebeenputforward
for the function of the polybasic domain in STIM1. Some have
suggested that it interacts directly with Orai1 to regulate the
activity of the channel [17], while others have proposed that it
is targeted to the PM by an interaction with some constituent(s)
within the PM itself [8]. It has been suggested that the polybasic
domainmaydirecttherecruitmentofSTIM1toER–PMjunctions
by binding directly to the phosphoinositides PtdIns(4,5)P2 and
PtdIns(3,4,5)P3 via electrostatic interactions as is the case for
smallGTPaseswithpolybasictails[25].Ourstudiesareconsistent
with this hypothesis.
The results of the present study also show that the phos-
phoinositides contribute to SOCE since depletion of phospho-
inositides signiﬁcantly reduced thapsigargin-induced Ca
2+ entry.
Extensivephosphoinositidedepletionresultedina94%reduction
in STIM1 puncta formation, but only a 60% overall reduction
in the peak ﬂuo-4 ﬂuorescence ratio. It should be noted,
however, that the ﬂuorescence ratio is not linearly related to
[Ca
2+]i leading to an underestimate of the degree of inhibition
of SOCE and suggesting that phosphoinositides do play a
crucial role in these conditions. The partial inhibitory effects
of depletion of individual phosphoinositides on STIM1 puncta
formation is consistent with previous ﬁndings on the effects of
inhibitionofPI3K[35]andPI4K[36,37]onagonist-inducedCa
2+
inﬂux. In addition, some studies have reported the inhibition of
SOCE and ICRAC by the simultaneous inhibition of PI3K/PI4K
[22,24]. Broad et al. [22] used high levels of wortmannin to
inhibit both PI3K and PI4K and consequently blocked both
Ca
2+ inﬂux and ICRAC in rat basophilic leukaemia cells. The
authors observed that this effect was not due to a decrease
in Ins(1,4,5)P3 and DAG (diacylglycerol) production but could
not determine the precise mechanism for the phosphoinositides
in SOC activity. Others [24] have used LY294002 to inhibit
PI3K/PI4K activity in platelets and suggested that these kinases
are involved in mediating Ca
2+ entry through a mechanism which
involves the re-organization of the actin cytoskeleton following
store depletion. However, our present ﬁndings imply that it is
probable that the phosphoinositides contribute to the regulation
of Ca
2+ inﬂux through the recruitment of STIM1 to the PM
following store depletion, since STIM1 puncta formation was
substantially inhibited when PM phosphoinositides are depleted
bytreatmentwitheitherwortmanninorLY294002andhydrolysis
of PtdIns(4,5)P2 by an inducible phosphatase. The lower
concentration of LY294002 that was used in the present study has
beenreportedtohavelittleeffectonPI4K[28].Weestablishedthat
atthelow(50 μM)concentrationofLY294002,dissociationfrom
the Golgi complex of the PtdIns4P-speciﬁc PH domain reporter
FAPPI [38], as a marker of PI4K inhibition, was 2.5-fold less
that at the high (300μM) concentration (results not shown). The
effectivenessofthelowerconcentrationofLY294002ininhibiting
STIM1 puncta formation is consistent with key roles for the two
lipids PtdIns(4,5)P2 and PtdIns(3,4,5)P3, although we cannot rule
out an additional contribution of PtdIns4P.
A recent study [16] showed that a truncated STIM1 protein
lackingthepolybasicdomainfailstoformpunctawhenexpressed
alone in HEK-293 (human embryonic kidney) or HeLa cells but
doesredistributeintopunctaandactivateICRAC whenco-expressed
with Orai1 in the same cells, reconciling different effects reported
ofdeletionofthisdomain.Thisledtotheproposaloftwoseparate
mechanisms for the recruitment of STIM1 to the PM. STIM1 can
be anchored to the PM via a direct interaction of a region within
its C-terminal ERM domain with Orai1 [16–20]. Alternatively,
STIM1 can be recruited to ER–PM junctions via an Orai1-
independent mechanism involving its polybasic domain [8,16]. It
has been proposed that, under physiological conditions, the poly-
basic domain may initially direct STIM1 oligomers to ER–PM
junctions and thereby facilitate its interaction with and activation
of Orai1 [16]. This dual-targeting mechanism appears to be a
vertebrate adaptation since the polybasic domain is present only
invertebrateSTIMhomologues.Inthepresentstudy,weobserved
that STIM1 can effectively form puncta in cells depleted of PM
phosphoinositides when Orai1 is overexpressed in the same cells,
suggesting that the binding of STIM1 to the phosphoinositides is
not essential for puncta formation. We also tested whether SOCE
was recovered following phosphoinositide depletion by overex-
pression of Orai. Note that in our experiments overexpression of
bothSTIM1andOraiconstructsincontrolcellsdidnotproducean
increase in SOCE above that seen with STIM1 alone as described
in other studies [39–41]. Previous observations have, however,
been derived from the study of HEK-293 cells in which there is
littleendogenousSOCE[39–41]andpresumablylowlevelsofen-
dogenousOrai.OurresultsshowedthatOraioverexpressionresul-
ted in a recovery of SOCE in cells depleted of phosphoinositides.
Our present observations support the hypothesis that there are
twomechanismsforSTIM1targetingtothePM.Inaddition,Ca
2+
inﬂux was restored to above that of control levels in these cells.
These ﬁndings agree with several recent reports which suggest
that the interaction between the ERM domain of STIM1 and
Orai1 is necessary and sufﬁcient for the activation of SOCs
and does not require the polybasic domain [16–20]. Our
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observationsalsosuggesttwopotentialfunctionsforthephospho-
inositides in SOCE. Under physiological conditions, the
phosphoinositides may contribute to the activation of SOCe by
enhancingtherecruitmentofSTIM1toER–PMjunctions,thereby
increasing the likelihood of an interaction between STIM1 and
Orai1 for the activation of Ca
2+ inﬂux. Additionally, they might
regulate the ability of STIM1 to activate SOCs when bound
to Orai1, since Ca
2+ inﬂux is enhanced in the absence of the
phosphoinositides in cells co-expressing Orai1. It is possible that,
in the absence of the phosphoinositides, the ERM domain of
STIM1 is exposed, resulting in enhanced binding of the ERM do-
main to Orai1 and consequently increased Ca
2+ inﬂux. Enhanced
activation of SOCs by a STIM1 protein, which lacks a functional
polybasic domain, has previously been observed in cells co-
expressing Orai1 [17]. This regulatory mechanism may therefore
be required under physiological conditions to prevent over-
activation of the channels and may have evolved in vertebrates
as an additional mechanism to protect cells against Ca
2+ toxicity.
A study, which was published while this paper was in
preparation, investigated the role of the phosphoinositides in
STIM1- and Orai1-mediated Ca
2+ entry and found only a small
effect of phosphoinositide depletion on STIM1 puncta [42].
The experimental approach used in that study differed from
that in the present one since STIM1 translocation and puncta
formation were stimulated before subsequently depleting the
phosphoinositides using a combination of the PtdIns(4,5)P2-
speciﬁc inducible phosphatase system and high concentration
of LY294002. It is possible that, in these experiments, the pre-
formed STIM1 puncta might render PtdIns(4,5)P2 inaccessible to
the phosphatase, thereby preventing its efﬁcient hydrolysis. In the
present study, stimulation of STIM1 puncta formation by store
depletion was only carried out after the cells were treated with a
combinationofeitherwortmanninorLY294002andtheinducible
phosphatase. This would, thereby, ensure a reduction in the levels
of PM phosphoinositides prior to puncta formation. This method
proved to be effective in preventing STIM1 puncta formation.
Korzeniowskietal.[42]showedthatPLCactivationorPI3K/PI4K
inhibition by LY294002 reduced both ICRAC and SOCE in COS-7
cells, even under conditions where PtdIns(4,5)P2 levels remained
unchanged, suggesting that PtdIns(4)P rather than PtdIns(4,5)P2
is the major phosphoinositide required for activation of SOCs.
Our studies suggest that PtdIns(4,5)P2 and PtdIns(3,4,5)P3 are
the key lipids involved in targeting STIM1 to ER–PM junctions.
In summary, the present study conﬁrms that there are two
distinct modes of STIM1 translocation to the PM. One involves
a direct interaction between STIM1 and Orai1, the other
requiring PM phosphoinositides. We propose two functions
for this interaction in the regulation of SOCE. Initially, the
phosphoinositides may target STIM1 to ER–PM junctions to
facilitate its subsequent interaction with Orai1 at these sites.
In addition, the potential binding of the polybasic domain of
STIM1 to phosphoinositides may regulate the activity of the
Orai1channelbydeterminingtheextentofSTIM1–Orai1binding.
Furtherstudiesarerequiredtoconﬁrmadirectinteractionbetween
STIM1 and the various phosphoinositides and to determine the
extent to which each phosphoinositide species contributes to the
activity of SOCs.
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